133 related articles for article (PubMed ID: 38746402)
1. SAK3 confers neuroprotection in the neurodegeneration model of X-linked Dystonia-Parkinsonism.
Aryal S; Chen S; Burbach KF; Yang Y; Capano LS; Kim WK; Bragg DC; Yoo A
Res Sq; 2024 Apr; ():. PubMed ID: 38746402
[TBL] [Abstract][Full Text] [Related]
2. Proteomic analysis of X-linked dystonia parkinsonism disease striatal neurons reveals altered RNA metabolism and splicing.
Tshilenge KT; Bons J; Aguirre CG; Geronimo-Olvera C; Shah S; Rose J; Gerencser AA; Mak SK; Ehrlich ME; Bragg DC; Schilling B; Ellerby LM
Neurobiol Dis; 2024 Jan; 190():106367. PubMed ID: 38042508
[TBL] [Abstract][Full Text] [Related]
3. Decreased N-TAF1 expression in X-linked dystonia-parkinsonism patient-specific neural stem cells.
Ito N; Hendriks WT; Dhakal J; Vaine CA; Liu C; Shin D; Shin K; Wakabayashi-Ito N; Dy M; Multhaupt-Buell T; Sharma N; Breakefield XO; Bragg DC
Dis Model Mech; 2016 Apr; 9(4):451-62. PubMed ID: 26769797
[TBL] [Abstract][Full Text] [Related]
4. X-linked Dystonia-Parkinsonism patient cells exhibit altered signaling via nuclear factor-kappa B.
Vaine CA; Shin D; Liu C; Hendriks WT; Dhakal J; Shin K; Sharma N; Bragg DC
Neurobiol Dis; 2017 Apr; 100():108-118. PubMed ID: 28017799
[TBL] [Abstract][Full Text] [Related]
5. Dissection of
Capponi S; Stöffler N; Penney EB; Grütz K; Nizamuddin S; Vermunt MW; Castelijns B; Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Muñoz EL; Ang MA; Diesta CCE; Creyghton MP; Klein C; Bragg DC; De Rijk P; Timmers HTM
Brain Commun; 2021; 3(4):fcab253. PubMed ID: 34746789
[TBL] [Abstract][Full Text] [Related]
6. Altered glutamate response and calcium dynamics in iPSC-derived striatal neurons from XDP patients.
Capetian P; Stanslowsky N; Bernhardi E; Grütz K; Domingo A; Brüggemann N; Naujock M; Seibler P; Klein C; Wegner F
Exp Neurol; 2018 Oct; 308():47-58. PubMed ID: 29944858
[TBL] [Abstract][Full Text] [Related]
7. Variation in TAF1 expression in female carrier induced pluripotent stem cells and human brain ontogeny has implications for adult neostriatum vulnerability in X-linked Dystonia Parkinsonism.
D'Ignazio L; Jacomini RS; Qamar B; Benjamin KJM; Arora R; Sawada T; Evans TA; Diffenderfer KE; Pankonin AR; Hendriks WT; Hyde TM; Kleinman JE; Weinberger DR; Bragg DC; Paquola ACM; Erwin JA
eNeuro; 2022 Jul; 9(4):. PubMed ID: 35868859
[TBL] [Abstract][Full Text] [Related]
8. Promise and challenges of dystonia brain banking: establishing a human tissue repository for studies of X-Linked Dystonia-Parkinsonism.
Fernandez-Cerado C; Legarda GP; Velasco-Andrada MS; Aguil A; Ganza-Bautista NG; Lagarde JBB; Soria J; Jamora RDG; Acuña PJ; Vanderburg C; Sapp E; DiFiglia M; Murcar MG; Campion L; Ozelius LJ; Alessi AK; Singh-Bains MK; Waldvogel HJ; Faull RLM; Macalintal-Canlas R; Muñoz EL; Penney EB; Ang MA; Diesta CCE; Bragg DC; Acuña-Sunshine G
J Neural Transm (Vienna); 2021 Apr; 128(4):575-587. PubMed ID: 33439365
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological Phenotype and Genetics of X-Linked Dystonia-Parkinsonism (XDP; DYT3; Lubag).
Kawarai T; Morigaki R; Kaji R; Goto S
Brain Sci; 2017 Jun; 7(7):. PubMed ID: 28672841
[TBL] [Abstract][Full Text] [Related]
10. Age-related Huntington's disease progression modeled in directly reprogrammed patient-derived striatal neurons highlights impaired autophagy.
Oh YM; Lee SW; Kim WK; Chen S; Church VA; Cates K; Li T; Zhang B; Dolle RE; Dahiya S; Pak SC; Silverman GA; Perlmutter DH; Yoo AS
Nat Neurosci; 2022 Nov; 25(11):1420-1433. PubMed ID: 36303071
[TBL] [Abstract][Full Text] [Related]
11. The Effect of Glucocorticoids on
Cruz SED; Bagamasbad P
J ASEAN Fed Endocr Soc; 2023; 38(1):23-30. PubMed ID: 37234925
[TBL] [Abstract][Full Text] [Related]
12. Postnatal Conditional Deletion of
Song S; Creus Muncunill J; Galicia Aguirre C; Tshilenge KT; Hamilton BW; Gerencser AA; Benlhabib H; Cirnaru MD; Leid M; Mooney SD; Ellerby LM; Ehrlich ME
Biomedicines; 2022 Sep; 10(10):. PubMed ID: 36289639
[TBL] [Abstract][Full Text] [Related]
13. Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat.
Campion LN; Mejia Maza A; Yadav R; Penney EB; Murcar MG; Correia K; Gillis T; Fernandez-Cerado C; Velasco-Andrada MS; Legarda GP; Ganza-Bautista NG; Lagarde JBB; Acuña PJ; Multhaupt-Buell T; Aldykiewicz G; Supnet ML; De Guzman JK; Go C; Sharma N; Munoz EL; Ang MC; Diesta CCE; Bragg DC; Ozelius LJ; Wheeler VC
Acta Neuropathol Commun; 2022 Apr; 10(1):49. PubMed ID: 35395816
[TBL] [Abstract][Full Text] [Related]
14. A scoping review on the diagnosis and treatment of X-linked dystonia-parkinsonism.
Alonto AHD; Jamora RDG
Parkinsonism Relat Disord; 2024 Feb; 119():105949. PubMed ID: 38072720
[TBL] [Abstract][Full Text] [Related]
15. Neuroimaging and neuropathology studies of X-linked dystonia parkinsonism.
Arasaratnam CJ; Singh-Bains MK; Waldvogel HJ; Faull RLM
Neurobiol Dis; 2021 Jan; 148():105186. PubMed ID: 33227492
[TBL] [Abstract][Full Text] [Related]
16. Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex.
Petrozziello T; Mills AN; Vaine CA; Penney EB; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña-Sunshine G; Ozelius LJ; Sharma N; Bragg DC; Sadri-Vakili G
Neurobiol Dis; 2020 Oct; 144():105032. PubMed ID: 32739252
[TBL] [Abstract][Full Text] [Related]
17. A hexanucleotide repeat modifies expressivity of X-linked dystonia parkinsonism.
Westenberger A; Reyes CJ; Saranza G; Dobricic V; Hanssen H; Domingo A; Laabs BH; Schaake S; Pozojevic J; Rakovic A; Grütz K; Begemann K; Walter U; Dressler D; Bauer P; Rolfs A; Münchau A; Kaiser FJ; Ozelius LJ; Jamora RD; Rosales RL; Diesta CCE; Lohmann K; König IR; Brüggemann N; Klein C
Ann Neurol; 2019 Jun; 85(6):812-822. PubMed ID: 30973967
[TBL] [Abstract][Full Text] [Related]
18. Oculomotor abnormalities indicate early executive dysfunction in prodromal X-linked dystonia-parkinsonism (XDP).
Mertin R; Diesta C; Brüggemann N; Rosales RL; Hanssen H; Westenberger A; Steinhardt J; Heldmann M; Manalo HTS; Oropilla JQ; Klein C; Helmchen C; Sprenger A
J Neurol; 2023 Sep; 270(9):4262-4275. PubMed ID: 37191726
[TBL] [Abstract][Full Text] [Related]
19. X-linked dystonia parkinsonism: epidemiology, genetics, clinical features, diagnosis, and treatment.
Chin HL; Lin CY; Chou OH
Acta Neurol Belg; 2023 Feb; 123(1):45-55. PubMed ID: 36418540
[TBL] [Abstract][Full Text] [Related]
20. Oral diadochokinetic markers of X-linked dystonia-parkinsonism.
Kao TH; Rowe HP; Green JR; Stipancic KL; Sharma N; de Guzman JK; Supnet-Wells ML; Acuna P; Perry BJ
Parkinsonism Relat Disord; 2024 Mar; 120():105991. PubMed ID: 38184995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
